Federal contract award

75N93019F00131

ANIMAL MODEL DEVELOPMENT AND INITIAL EFFICACY TESTING

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTES OF HEALTH NIAID
NAICS541711
PSCAN81 — AIDS RESEARCH - BASIC RESEARCH
Parent award / vehicleHHSN272201500013I
Set-asideNot reported
Pricing typeCOST PLUS FIXED FEE
Obligations$9.4M
Current contract value$9.4M
Potential contract value / ceiling$9.4M
Start dateSep 30, 2019
Current end dateDec 10, 2021
Potential end dateDec 10, 2021
Latest award activityNov 8, 2021
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 10 of 10 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Nov 8, 2021P00009$0EO14042 RADIATION/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT SERVICES EDITED BY LNGUYEN_NIH ON 11/08/2021 16:32:24 EDITED BY LNGUYEN_NIH ON 11/08/2021 16:32:35
Jun 15, 2021P00008$610.0KRADIATION/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT SERVICES
Apr 8, 2021P00007$578.1KRADIATION/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT SERVICES
Dec 10, 2020P00006$0RADIATION/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT SERVICES
Aug 18, 2020P00005$2.9MRADIATION/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT SERVICES
Jun 15, 2020P00004$0RADIATION/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT SERVICES
Mar 23, 2020P00003$0RADIATION/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT SERVICES
Dec 6, 2019P00002$0TO REVISE ARTICLE B.3. ADVANCE UNDERSTANDINGS, SUBCONTRACT.
Nov 18, 2019P00001$0TO REVISE ARTICLE B.3. ADVANCE UNDERSTANDINGS, SUBCONTRACT.
Sep 24, 20190$5.3MANIMAL MODEL DEVELOPMENT AND INITIAL EFFICACY TESTING

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.